US 7531173
Ophthalmic composition of a VEGF antagonist
granted A61KA61K38/00A61K38/13
Quick answer
US patent 7531173 (Ophthalmic composition of a VEGF antagonist) held by REGENERON PHARMACEUTICALS, INC. expires Mon May 07 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue May 12 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 07 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61K, A61K38/00, A61K38/13, A61K45/06, A61K9/0019